Comparative Study of Rifaximin Versus Norfloxacin in the Secondary Prophylaxis of Spontaneous Bacterial Peritonitis

NCT02120196 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Spontaneous Bacterial Peritonitis
Ascites
Liver Cirrhosis

Interventions

DRUG: Rifaximin
DRUG: Norfloxacin

Sponsor

Sherief Abd-Elsalam

Collaborators

[object Object]